SEC Tracker
Get the app

Metagenomi Therapeutics MGX

Metagenomi Therapeutics: annual report to shareholders

Form
ARS
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

Annual report to shareholders

View on EDGAR

Open in the app

Get an email when Metagenomi Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Fitlife Brands FTLF public float $51M, Jun 30, 2025
  2. Immucell ICCC public float $51M, Jun 30, 2025
  3. Cue Biopharma CUE public float $52M, Jun 30, 2025
  4. Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
  5. Precision Biosciences DTIL public float $47M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.